Drawing for MAMMAPLUS CONTRA

USPTO serial 77607903

MAMMAPLUS CONTRA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CARL III, FRED
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAMMAPLUS CONTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bryan Walser, MD

309 University DriveMenlo Park, CA 94025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test kits comprised primarily of reagents and assays for scientific useACTIVE—
005Diagnostic preparations and reagents for medical clinic and medical use; diagnostic preparations and reagents for medical clinic and medical laboratory use; diagnostic test kits comprised primarily of reagents and assays for medical clinic and medical useACTIVE—
042Providing reagent sample testing and diagnostic services for others in the fields of science and medical research; biotechnology research and development services for others, namely, genetic association studies, genome mapping, genome analysis, genome scanning all for research purposes; biotechnology research and development services for others, namely, pharmaceutical drug and therapeutics development, consumer health product development and consultation in the field of genomics and pharmaceutical drug development; Providing reagent sample testing and diagnostic services for others in the field of medicine; biotechnology research and development services for others, namely, genetic association studies, genome mapping, genome analysis, genome scanning all for medical treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 16, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 16, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 11, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 12, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 20, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 10, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Sep 10, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 10, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 10, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 4, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 21, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 21, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 11, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Aug 11, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 11, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 11, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 31, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 21, 2009MAILPAPER RECEIVED—
Jul 20, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 20, 2009ALIEASSIGNED TO LIE—
Jul 10, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 8, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Jul 8, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 8, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 8, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 30, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 30, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2009GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 6, 2009GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 6, 2009CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 5, 2009DOCKASSIGNED TO EXAMINER—
Nov 11, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Nov 10, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance